3-(3-(p-Tolyl)-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine

ID: ALA4535365

PubChem CID: 58345215

Max Phase: Preclinical

Molecular Formula: C18H15N5

Molecular Weight: 301.35

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1ccc(-n2c(-c3cccnc3N)nc3cccnc32)cc1

Standard InChI:  InChI=1S/C18H15N5/c1-12-6-8-13(9-7-12)23-17(14-4-2-10-20-16(14)19)22-15-5-3-11-21-18(15)23/h2-11H,1H3,(H2,19,20)

Standard InChI Key:  ATCBNRSBCPIMBZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    4.0007   -3.1122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.4628   -2.4381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9617   -1.7893    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2163   -2.8829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1942   -2.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4788   -1.6818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7850   -2.1090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8112   -2.9266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5270   -3.3093    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2774   -2.4157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7053   -3.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5215   -3.0903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9106   -2.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4777   -1.6727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6630   -1.6990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2761   -3.8795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7451   -4.5022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0192   -5.2712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8238   -5.4188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3538   -4.7912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0769   -4.0246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2326   -1.0043    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.0995   -6.1881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  1  1  0
  1  2  1  0
  2  3  2  0
  3  5  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  2 10  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  1 16  1  0
 15 22  1  0
 19 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4535365

   3-(3-p-tolyl-3H-imidazo[4,5-b]pyridine-2-yl)pyridine-2-amine

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 301.35

Molecular Weight (Monoisotopic): 301.1327

AlogP: 3.37

#Rotatable Bonds: 2

Polar Surface Area: 69.62

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 5.89

CX LogP: 3.38

CX LogD: 3.36

Aromatic Rings: 4

Heavy Atoms: 23

QED Weighted: 0.62

Np Likeness Score: -1.21

References

1. Lapierre JM, Eathiraj S, Vensel D, Liu Y, Bull CO, Cornell-Kennon S, Iimura S, Kelleher EW, Kizer DE, Koerner S, Makhija S, Matsuda A, Moussa M, Namdev N, Savage RE, Szwaya J, Volckova E, Westlund N, Wu H, Schwartz B..  (2016)  Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor.,  59  (13): [PMID:27305487] [10.1021/acs.jmedchem.6b00619]

Source

Source(1):

• Scientific Literature